SCHEMBL175403

SCHEMBL175403

CSCC[C@H](NC(=O)c1ccc(C#CC#Cc2ccc(N)cc2)cc1)C(=O)O

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CA2 P00918 5/20 0.61
CA1 P00915 3/20 0.61
CA12 O43570 2/20 0.52
CA9 Q16790 2/20 0.52
ALDH1A1 P00352 3/20 0.51
USP2 O75604 1/20 0.51
TP53 P04637 1/20 0.51
ALOX15 P16050 1/20 0.51
MAPK1 P28482 1/20 0.51
NPSR1 Q6W5P4 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.47
FOLH1 Q04609 1/20 0.47
MEN1 O00255 1/20 0.45
CRHBP P24387 1/20 0.45
KMT2A Q03164 1/20 0.45
CRHR2 Q13324 1/20 0.45
FNTA P49354 3/20 0.45
FNTB P49356 3/20 0.45
PGGT1B P53609 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9432949 0.90 CA2 (0.72) CA2CA1CA12CA9ALDH1A1
SCHEMBL9830498 0.90 CA2 (0.72) CA2CA1CA12CA9ALDH1A1
SCHEMBL15227748 0.84 CA2 (0.58) CA2CA1CA12CA9FOLH1
SCHEMBL15228151 0.83 CA2 (0.49) CA2CA1ALDH1A1L3MBTL1
SCHEMBL15227746 0.83 CA2 (0.57) CA2CA1CA12CA9ALDH1A1
SCHEMBL175667 0.82 CA2 (0.58) CA2CA1CA12CA9
SCHEMBL15904233 0.82 CA2 (0.64) CA2CA1CA12CA9ALDH1A1
SCHEMBL15227888 0.82 CA2 (0.56) CA2CA1ALDH1A1L3MBTL1
SCHEMBL159840 0.81 CA2 (0.47) CA2CA1ALDH1A1L3MBTL1
Cysteine SCHEMBL8365455 0.81 CA2 (0.60) CA2CA1CA12CA9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10597361-B2 Ethynylbenzene derivatives DUKE UNIVERSITY (US) 2020-03-24 US disclosed
US-20170349544-A1 Ethynylbenzene Derivatives DUKE UNIVERSITY 2017-12-07 US disclosed
US-9738604-B2 Ethynylbenzene derivatives DUKE UNIVERSITY (US) 2017-08-22 US disclosed
US-20130231323-A1 ETHYNYLBENZENE DERIVATIVES DUKE UNIVERSITY (US) 2013-09-05 US disclosed
WO-2012031298-A2 ETHYNYLBENZENE DERIVATIVES DUKE UNIVERSITY (US) 2012-03-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10597361-B2 Ethynylbenzene derivatives Q6ZSR9, EPX, ZYX CA2 3434/4885CA1 4842/4885CA12 3350/4885
US-20170349544-A1 Ethynylbenzene Derivatives Q6ZSR9, EPX, ZYX CA2 3434/4885CA1 4842/4885CA12 3350/4885
US-20130231323-A1 ETHYNYLBENZENE DERIVATIVES Q6ZSR9, EPX, ZYX CA2 3434/4885CA1 4842/4885CA12 3350/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.